September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
Selling Amazon On Recession Risks (Downgrade)
Amazon: See The Company From A Different Perspective
Amazon: Intact Dual Market Leadership
Amazon: Don’t Underestimate The Potential Of AWS To Drive The Stock Higher
Apple: The Real Boost Behind Vision Pro And AI Phones
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Vaccinex (VCNX) stock forecast for 2025
Updated: September 19, 2024 (05:27)
Sector: HealthcareThe share price of Vaccinex, Inc. (VCNX) now
50/200 Day Moving Average: $5.81 / $7.11
This figure corresponds to the Average Price over the previous 50/200 days. For Vaccinex stocks, the 50-day moving average is the resistance level today.
For Vaccinex stocks, the 200-day moving average is the resistance level today.
Are you interested in Vaccinex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Vaccinex stock price in 2025. How much will one Vaccinex share be worth in 2025? Is it worth taking profit / loss on VCNX stock now or waiting? What are analysts' forecasts for Vaccinex stock?
We forecast Vaccinex stock performance using neural networks based on historical data on VCNX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Vaccinex, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Vaccinex analysts is $7. Today 200 Day Moving Average is the resistance level (7.11 $). 50 Day Moving Average is the resistance level (5.81 $).
Historical and forecast chart of Vaccinex, Inc. stock
The chart below shows the historical price of Vaccinex stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the VCNX stock price can be found in the table below.
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s product pipeline includes pepinemab (VX15), which targets Huntington’s Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others.
Vaccinex (VCNX) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.13 | 3.72 | 4.25 | 12.53 % |
| Feb | 3.66 | 3.32 | 3.89 | 14.75 % |
| Mar | 3.62 | 3.30 | 4.02 | 17.92 % |
| Apr | 3.76 | 3.61 | 4.11 | 12.30 % |
| May | 3.73 | 3.62 | 3.88 | 6.59 % |
| Jun | 3.53 | 3.33 | 3.79 | 12.25 % |
| Jul | 3.40 | 3.13 | 3.72 | 15.74 % |
| Aug | 3.14 | 3.01 | 3.49 | 13.74 % |
| Sep | 2.96 | 2.65 | 3.24 | 18.18 % |
| Oct | 3.15 | 2.90 | 3.47 | 16.28 % |
| Nov | 3.57 | 3.21 | 3.84 | 16.42 % |
| Dec | 3.85 | 3.55 | 4.21 | 15.87 % |
Vaccinex information and performance
1895 MOUNT HOPE AVE, ROCHESTER, NY, US
Market capitalization of the Vaccinex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of VCNX shares in the company outstanding by the market price of one share.
EBITDA of Vaccinex is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Vaccinex price target for 2025 by month
Target values for the price of one Vaccinex share for Jan 2025.
In Jan, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 12.529% volatility is expected.
Pessimistic target level: 3.72
Optimistic target level: 4.25
Target values for the price of one Vaccinex share for Feb 2025.
In Feb, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 14.751% volatility is expected.
Pessimistic target level: 3.32
Optimistic target level: 3.89
Target values for the price of one Vaccinex share for Mar 2025.
In Mar, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 17.923% volatility is expected.
Pessimistic target level: 3.30
Optimistic target level: 4.02
Target values for the price of one Vaccinex share for Apr 2025.
In Apr, the Positive dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 12.303% volatility is expected.
Pessimistic target level: 3.61
Optimistic target level: 4.11
Target values for the price of one Vaccinex share for May 2025.
In May, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 6.592% volatility is expected.
Pessimistic target level: 3.62
Optimistic target level: 3.88
Target values for the price of one Vaccinex share for Jun 2025.
In Jun, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 12.251% volatility is expected.
Pessimistic target level: 3.33
Optimistic target level: 3.79
Target values for the price of one Vaccinex share for Jul 2025.
In Jul, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 15.743% volatility is expected.
Pessimistic target level: 3.13
Optimistic target level: 3.72
Target values for the price of one Vaccinex share for Aug 2025.
In Aug, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 13.740% volatility is expected.
Pessimistic target level: 3.01
Optimistic target level: 3.49
Target values for the price of one Vaccinex share for Sep 2025.
In Sep, the Negative dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 18.175% volatility is expected.
Pessimistic target level: 2.65
Optimistic target level: 3.24
Target values for the price of one Vaccinex share for Oct 2025.
In Oct, the Positive dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 16.279% volatility is expected.
Pessimistic target level: 2.90
Optimistic target level: 3.47
Target values for the price of one Vaccinex share for Nov 2025.
In Nov, the Positive dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 16.422% volatility is expected.
Pessimistic target level: 3.21
Optimistic target level: 3.84
Target values for the price of one Vaccinex share for Dec 2025.
In Dec, the Positive dynamics for Vaccinex, Inc. shares will prevail with possible monthly volatility of 15.871% volatility is expected.
Pessimistic target level: 3.55
Optimistic target level: 4.21
Related stocks from Healthcare sector
